Abstract:Background Proliferative diabetes retinopathy (PDR) seriously affects the vision of patients. Exploring the key genes of retinal neovascularization is crucial for developing new biomarkers and therapeutic targets. Objective This study aimed to identify key genes associated with retinal neovascularization in Proliferative Diabetic Retinopathy (PDR), intending to develop new biomarkers and therapeutic targets. This would further our understanding of the progression of diabetic retinopathy and improve patient prognosis. Methods The gene data from 36 diabetic retinopathy patient samples and 45 samples from healthy volunteers or diabetic patients were selected from the GEO DataSets (Gene Expression Omnibus), specifically datasets GSE102485 and GSE160310. Utilizing the SVA algorithm to merge datasets and the limma package in R to identify differentially expressed genes (DEGs), we conducted a bioinformatic analysis of diabetic retinopathy. Functional insights were gained through DAVID database analyses, while STRING database-derived Protein-Protein Interaction (PPI) networks visualized in Cytoscape provided further context. Key genes were identified through LASSO regression and SVM analyses, with ROC curves assessing their diagnostic value. Single gene set enrichment analysis (GSEA) enhanced our understanding of the perturbed biological processes and pathways, advancing knowledge of diabetic retinopathy at the genomic level. Results A rigorous bioinformatic analysis yielded a comprehensive list of 1139 differentially expressed genes (DEGs), of which six pivotal genes—KDM5D, AC007040.11, AC015688.3, NLRP2, GYPC, and TMSB4Y—were identified as central to the study. These six genes consistently demonstrated a high diagnostic accuracy, with each exhibiting an area under the receiver operating characteristic (ROC) curve (AUC) exceeding 0.75. Gene Ontology (GO) enrichment analysis elucidated their primary roles in intricate biological processes, including inflammatory and immune responses, T-cell activation, cell apoptosis, and angiogenesis. Moreover, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment revealed their involvement in crucial signaling cascades such as cytokine-cytokine receptor interactions, cell adhesion molecule pathways, PI3K-Akt signaling, and hematopoietic cell lineage, further substantiating their significance in the pathogenesis of diabetic retinopathy. Conclusions In this research, we conducted a comprehensive gene expression analysis in patients with and without PDR, identifying differentially expressed genes, pivotal biomarkers, and critical pathways potentially involved in PDR progression. Our findings enhance understanding of PDR's molecular dynamics and offer potential avenues for improved prognostication and therapeutic intervention, despite limitations due to sample group heterogeneity.

Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy

Angiopoietin-like 4 Binds Neuropilins and Cooperates with VEGF to Induce Diabetic Macular Edema

Angiopoietin–Tie Signaling Pathway in Diabetic Retinopathy

ANGPTL-4 correlates with vascular endothelial growth factor in patients with proliferative diabetic retinopathy

Induced Expression of VEGFC, ANGPT, and EFNB2 and Their Receptors Characterizes Neovascularization in Proliferative Diabetic Retinopathy.

Angiopoietin-Like Protein 4 (ANGPTL4) Induces Retinal Pigment Epithelial Barrier Breakdown by Activating Signal Transducer and Activator of Transcription 3 (STAT3): Evidence from ARPE-19 Cells under Hypoxic Condition and Diabetic Rats

ANGPTL-4 induces diabetic retinal inflammation by activating Profilin-1.

PI3Kδ as a Novel Therapeutic Target in Pathological Angiogenesis.

Proliferative diabetic retinopathy transcriptomes reveal angiogenesis, anti-angiogenic therapy escape mechanisms, fibrosis and lymphatic involvement

VEGF Secreted by Hypoxic Müller Cells Induces MMP-2 Expression and Activity in Endothelial Cells to Promote Retinal Neovascularization in Proliferative Diabetic Retinopathy.

PAI-1 is a vascular cell–specific HIF-2–dependent angiogenic factor that promotes retinal neovascularization in diabetic patients

ANGPTL4 influences the therapeutic response of patients with neovascular age-related macular degeneration by promoting choroidal neovascularization

The Role of Angiogenesis in the Development of Proliferative Diabetic Retinopathy: Impact of Intravitreal Anti-VEGF Treatment

ADAMTS5 promotes neovascularization via autophagic degradation of PEDF in proliferative diabetic retinopathy

Identification and functional analysis of novel biomarkers related to retinal neovascularization in proliferative diabetic retinopathy

Inhibitor of Growth 4 Affects Hypoxia-Induced Migration and Angiogenesis Regulation in Retinal Pigment Epithelial Cells

PGF2α Facilitates Pathological Retinal Angiogenesis by Modulating Endothelial FOS‐driven ELR + CXC Chemokine Expression

Endothelial Adenosine A2a Receptor-Mediated Glycolysis is Essential for Pathological Retinal Angiogenesis.

Endothelial progenitor cells in diabetic retinopathy

Exploring the Association of VEGF-A and ANGPTL2 with the Prognosis of Non-proliferative and Proliferative Diabetic Retinopathy

Small GTPase ARF6 controls VEGFR2 trafficking and signaling in diabetic retinopathy.